Jefferies Group LLC Checkpoint Therapeutics, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.75 - $5.0 $34,650 - $63,000
-12,600 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$2.01 - $4.01 $25,325 - $50,526
12,600 New
12,600 $36,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $348M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email